Calling All Brave TFSA Investors: 2 Tech Stocks to Buy in a Steep Selloff

Nuvei (TSX:NVEI) and Docebo (TSX:DCBO) are two hyper-growth stocks that may be worth a long-term spot in your TFSA fund.

| More on:
Target. Stand out from the crowd

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

It takes a really brave investor to even think about scooping up stocks amid the bear market wreckage. Stock valuations have gotten much better over the past year. With lowered expectations come more food for the next potential rally. Undoubtedly, the next recession seems like one that everybody, even non-market participants, has had ample time to prepare for.

With the Fed staying on track with its inflation fight, I think expectations are a tad too low. Eventually, rate hikes will stop, and earnings will begin to creep higher again. Now, it’s difficult to say how this bear market will stack up historically. Regardless, buying bear markets over time tends to be a decent call over a long-term perspective.

Indeed, 2023 could be another weak year for investors. But that doesn’t mean you can’t finish with above-average results, especially if the hardest-hit part of this market begins to calm after spending most of 2022 in severely oversold territory.

Hunting value in the hyper-growth plays

At this juncture, many investors wouldn’t dare jump into the market’s deep end: the hyper-growth tech scene. Higher interest rates are essentially kryptonite for these types of stocks. Still, the bond market leaves room for optimism. Whether rate cuts will follow another hike or two remains a mystery. Regardless, I think we’re closer to peak rates than at this time last year!

If anything, central banks may have the incentive to give high-tech innovators some relief once they’re confident enough to announce they’ve delivered enough blows to slay the dragon of inflation. Over the long haul, it’s innovation that can have a longer-term disinflationary impact.

With that in mind, I think it’s not too far-fetched to think the Fed will lower the bar on rates once inflation is no longer an issue. Recent data suggests inflation is going back into hibernation. In other words, the bear is heading back to its cave. For now, though, the Fed wants to err on the side of caution and wait until the bear has actually set foot in its cave before pausing and contemplating next steps (potential rate cuts).

Now, I’d never buy a stock with the expectation that rates will peak and come down. However, longer-term, I think there’s value to be had in hyper-growth names.

Nuvei (TSX:NVEI) and Docebo (TSX:DCBO) stand out as innovators that have fallen too hard.

Nuvei: Making the most of a tech wreck

Nuvei is a payment firm that fell more than 80% from peak to trough. That’s a huge blow to the gut. But the pain may be nearing the end, with the recent 34% bounce off bottom. Further, Nuvei seems to be making the most of the tough times endured by all of tech. Recently, Nuvei opened up its wallet, committing to buy a U.S. firm Paya in a deal worth US$1.3 billion. Better yet, Nuvei is using all cash to fund the deal, implying that there’s deep value to be had in the battered fintech scene.

I’m a big fan of the deal. Paya is a top payment processor south of the border and could complement Nuvei’s assets quite well.

Docebo and the power of AI

As for Docebo, shares are recovering after a nearly 70% fall from peak to trough. The learning management system (LMS) enjoyed work-from-home tailwinds in 2020 and 2021.

Now, the tides are turning lower, but the firm continues to leverage the power of AI to help its clients become more productive. AI is a big deal. Many of us learned of its potential when OpenAI launched its ChatGPT software. As one of the most promising AI players, Docebo is very intriguing for those brave enough to buy hyper-growth while times are tough.

Bottom line

Docebo and Nuvei are great hyper-growth plays for the long run (the next 10 years). Don’t expect huge gains overnight, though. Those days are long gone.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Nuvei. The Motley Fool recommends Docebo. The Motley Fool has a disclosure policy.

More on Investing

Investing

KM Throwaway Post

Read more »

Investing

Carlos Test Yoast Metadata

Read more »

Investing

KM Ad Test

This is my excerpt.

Read more »

Investing

Test post for affiliate partner mockups

Updated: 9/17/2024. This post was not sponsored. The views and opinions expressed in this review are purely those of the…

Read more »

Investing

Testing Ecap Error

Premium content from Motley Fool Stock Advisor We here at Motley Fool Stock Advisor believe investors should own at least…

Read more »

Investing

TSX Today: Testing the Ad for James

la la la dee dah.

Read more »

Lady holding remote control pointed towards a TV
Investing

2 Streaming Stocks to Buy Now and 1 to Run From

There are streaming stocks on the TSX that are worth paying attention to in 2023 and beyond.

Read more »

A red umbrella stands higher than a crowd of black umbrellas.
Stocks for Beginners

Top Recession-Resilient TSX Stocks to Buy With $3,000

It's time to increase your exposure to defensives!

Read more »